Lyka Labs Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company filed the mandatory certificate for the quarter ended 31st March, 2026, demonstrating adherence to dematerialisation compliance standards.

Regulatory Filing Details

The company submitted the certificate on 7th April, 2026, to both major stock exchanges where its shares are listed. Company Secretary Shailendra Kumar Agrawal signed the submission, ensuring proper corporate governance protocols were followed.

Registrar Confirmation

MUFG Intime India Private Limited (formerly Link Intime India Private Limited) served as the registrar and share transfer agent, providing the underlying certificate. The registrar confirmed that all securities received from depository participants for dematerialisation during Q4 FY26 were properly processed.

Key confirmations from the registrar included:

• All securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed

Compliance Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 requires companies to submit quarterly certificates confirming proper handling of dematerialisation processes. This regulation ensures transparency in the conversion of physical securities to electronic form and maintains investor protection standards.

The filing represents routine compliance activity, demonstrating the company's commitment to maintaining regulatory standards and ensuring proper handling of shareholder securities through authorised depositories and participants.

Lyka Labs Limited's Board of Directors conducted a meeting on 31st March, 2026, to address critical auditing appointments following recent organizational changes. The board meeting, which ran from 12:00 pm to 1:35 pm, focused on filling a casual vacancy in the Cost Auditor position and securing auditing services for the upcoming financial year.

Key Board Decisions

The board approved two significant appointments related to cost auditing services. M/s. Nidhi Subhash Tibrewala & Co., Cost Accountants with Firm Registration Number 005417, was selected to handle the company's cost auditing requirements. This appointment addresses both immediate and future auditing needs of the organization.

Reason for Appointment

The appointment for financial year 2025-26 was necessitated by a casual vacancy created due to the resignation of the previous Cost Auditors, M/s. Rajaram M Walavalkar & Co. This change required immediate board action to ensure continuity in the company's cost auditing processes. The board also proactively appointed the same firm for the financial year 2026-27, providing stability and consistency in auditing services.

About the New Cost Auditors

M/s. Nidhi Subhash Tibrewala & Co. is a Mumbai-based firm of practicing Cost Accountants that offers a comprehensive range of services to its clientele. The firm brings professional expertise in cost accounting and auditing practices, positioning it well to handle Lyka Labs' auditing requirements across multiple financial years.

Regulatory Compliance

The appointments were made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled its disclosure obligations by providing detailed information about the appointments, including the reasons for change and brief profiles of the appointed auditors. All relevant information has been made available on the company's website at www.lykalabs.com , ensuring transparency for stakeholders and regulatory compliance.